1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global urea cycle disorder treatment market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global urea cycle disorder treatment market 2017 – 2021 ($ million)
o 4.2 Therapy Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Therapy Segment 2017 – 2021 ($ million)
o 4.3 Route of Administration Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Route of Administration Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Therapy
o 6.1 Market segments
o Exhibit 30: Chart on Therapy – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy – Market share 2022-2027 (%)
o 6.2 Comparison by Therapy
o Exhibit 32: Chart on Comparison by Therapy
o Exhibit 33: Data Table on Comparison by Therapy
o 6.3 Glycerol phenylbutyrate – Market size and forecast 2022-2027
o Exhibit 34: Chart on Glycerol phenylbutyrate – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Glycerol phenylbutyrate – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Glycerol phenylbutyrate – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Glycerol phenylbutyrate – Year-over-year growth 2022-2027 (%)
o 6.4 Sodium phenylbutyrate – Market size and forecast 2022-2027
o Exhibit 38: Chart on Sodium phenylbutyrate – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Sodium phenylbutyrate – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Sodium phenylbutyrate – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Sodium phenylbutyrate – Year-over-year growth 2022-2027 (%)
o 6.5 Amino acid supplements – Market size and forecast 2022-2027
o Exhibit 42: Chart on Amino acid supplements – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Amino acid supplements – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Amino acid supplements – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Amino acid supplements – Year-over-year growth 2022-2027 (%)
o 6.6 Sodium benzoate – Market size and forecast 2022-2027
o Exhibit 46: Chart on Sodium benzoate – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Sodium benzoate – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Sodium benzoate – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Sodium benzoate – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Therapy
o Exhibit 54: Market opportunity by Therapy ($ million)
o Exhibit 55: Data Table on Market opportunity by Therapy ($ million)
7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 56: Chart on Route of Administration – Market share 2022-2027 (%)
o Exhibit 57: Data Table on Route of Administration – Market share 2022-2027 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 58: Chart on Comparison by Route of Administration
o Exhibit 59: Data Table on Comparison by Route of Administration
o 7.3 Oral – Market size and forecast 2022-2027
o Exhibit 60: Chart on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Oral – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Oral – Year-over-year growth 2022-2027 (%)
o 7.4 Injectables – Market size and forecast 2022-2027
o Exhibit 64: Chart on Injectables – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Injectables – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Injectables – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Injectables – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 68: Market opportunity by Route of Administration ($ million)
o Exhibit 69: Data Table on Market opportunity by Route of Administration ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 75: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 91: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 103: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 107: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 119: Abbott Laboratories – Overview
o Exhibit 120: Abbott Laboratories – Business segments
o Exhibit 121: Abbott Laboratories – Key news
o Exhibit 122: Abbott Laboratories – Key offerings
o Exhibit 123: Abbott Laboratories – Segment focus
o 12.4 Acer Therapeutics Inc.
o Exhibit 124: Acer Therapeutics Inc. – Overview
o Exhibit 125: Acer Therapeutics Inc. – Product / Service
o Exhibit 126: Acer Therapeutics Inc. – Key offerings
o 12.5 Aeglea BioTherapeutics Inc.
o Exhibit 127: Aeglea BioTherapeutics Inc. – Overview
o Exhibit 128: Aeglea BioTherapeutics Inc. – Product / Service
o Exhibit 129: Aeglea BioTherapeutics Inc. – Key offerings
o 12.6 Arcturus Therapeutics Holdings Inc.
o Exhibit 130: Arcturus Therapeutics Holdings Inc. – Overview
o Exhibit 131: Arcturus Therapeutics Holdings Inc. – Product / Service
o Exhibit 132: Arcturus Therapeutics Holdings Inc. – Key offerings
o 12.7 Bausch Health Co. Inc.
o Exhibit 133: Bausch Health Co. Inc. – Overview
o Exhibit 134: Bausch Health Co. Inc. – Business segments
o Exhibit 135: Bausch Health Co. Inc. – Key news
o Exhibit 136: Bausch Health Co. Inc. – Key offerings
o Exhibit 137: Bausch Health Co. Inc. – Segment focus
o 12.8 Boehringer Ingelheim International GmbH
o Exhibit 138: Boehringer Ingelheim International GmbH – Overview
o Exhibit 139: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 140: Boehringer Ingelheim International GmbH – Key news
o Exhibit 141: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 142: Boehringer Ingelheim International GmbH – Segment focus
o 12.9 CAMP4
o Exhibit 143: CAMP4 – Overview
o Exhibit 144: CAMP4 – Product / Service
o Exhibit 145: CAMP4 – Key offerings
o 12.10 Eurocept B.V.
o Exhibit 146: Eurocept B.V. – Overview
o Exhibit 147: Eurocept B.V. – Product / Service
o Exhibit 148: Eurocept B.V. – Key offerings
o 12.11 Horizon Therapeutics Plc
o Exhibit 149: Horizon Therapeutics Plc – Overview
o Exhibit 150: Horizon Therapeutics Plc – Business segments
o Exhibit 151: Horizon Therapeutics Plc – Key news
o Exhibit 152: Horizon Therapeutics Plc – Key offerings
o Exhibit 153: Horizon Therapeutics Plc – Segment focus
o 12.12 Medunik USA
o Exhibit 154: Medunik USA – Overview
o Exhibit 155: Medunik USA – Product / Service
o Exhibit 156: Medunik USA – Key offerings
o 12.13 Orpharma Pty Ltd.
o Exhibit 157: Orpharma Pty Ltd. – Overview
o Exhibit 158: Orpharma Pty Ltd. – Product / Service
o Exhibit 159: Orpharma Pty Ltd. – Key offerings
o 12.14 Recordati S.p.A
o Exhibit 160: Recordati S.p.A – Overview
o Exhibit 161: Recordati S.p.A – Business segments
o Exhibit 162: Recordati S.p.A – Key offerings
o Exhibit 163: Recordati S.p.A – Segment focus
o 12.15 RELIEF THERAPEUTICS Holding SA
o Exhibit 164: RELIEF THERAPEUTICS Holding SA – Overview
o Exhibit 165: RELIEF THERAPEUTICS Holding SA – Product / Service
o Exhibit 166: RELIEF THERAPEUTICS Holding SA – Key offerings
o 12.16 Synlogic Inc.
o Exhibit 167: Synlogic Inc. – Overview
o Exhibit 168: Synlogic Inc. – Product / Service
o Exhibit 169: Synlogic Inc. – Key offerings
o 12.17 Ultragenyx Pharmaceutical Inc.
o Exhibit 170: Ultragenyx Pharmaceutical Inc. – Overview
o Exhibit 171: Ultragenyx Pharmaceutical Inc. – Product / Service
o Exhibit 172: Ultragenyx Pharmaceutical Inc. – Key offerings
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global urea cycle disorder treatment market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Therapy Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Route of Administration Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Therapy – Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Glycerol phenylbutyrate – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Glycerol phenylbutyrate – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Glycerol phenylbutyrate – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Glycerol phenylbutyrate – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Sodium phenylbutyrate – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Sodium phenylbutyrate – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Sodium phenylbutyrate – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Sodium phenylbutyrate – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Amino acid supplements – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Amino acid supplements – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Amino acid supplements – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Amino acid supplements – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Sodium benzoate – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Sodium benzoate – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Sodium benzoate – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Sodium benzoate – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapy ($ million)
Exhibits55: Data Table on Market opportunity by Therapy ($ million)
Exhibits56: Chart on Route of Administration – Market share 2022-2027 (%)
Exhibits57: Data Table on Route of Administration – Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Route of Administration
Exhibits59: Data Table on Comparison by Route of Administration
Exhibits60: Chart on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Oral – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Oral – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Injectables – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Injectables – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Injectables – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Injectables – Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Route of Administration ($ million)
Exhibits69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories – Overview
Exhibits120: Abbott Laboratories – Business segments
Exhibits121: Abbott Laboratories – Key news
Exhibits122: Abbott Laboratories – Key offerings
Exhibits123: Abbott Laboratories – Segment focus
Exhibits124: Acer Therapeutics Inc. – Overview
Exhibits125: Acer Therapeutics Inc. – Product / Service
Exhibits126: Acer Therapeutics Inc. – Key offerings
Exhibits127: Aeglea BioTherapeutics Inc. – Overview
Exhibits128: Aeglea BioTherapeutics Inc. – Product / Service
Exhibits129: Aeglea BioTherapeutics Inc. – Key offerings
Exhibits130: Arcturus Therapeutics Holdings Inc. – Overview
Exhibits131: Arcturus Therapeutics Holdings Inc. – Product / Service
Exhibits132: Arcturus Therapeutics Holdings Inc. – Key offerings
Exhibits133: Bausch Health Co. Inc. – Overview
Exhibits134: Bausch Health Co. Inc. – Business segments
Exhibits135: Bausch Health Co. Inc. – Key news
Exhibits136: Bausch Health Co. Inc. – Key offerings
Exhibits137: Bausch Health Co. Inc. – Segment focus
Exhibits138: Boehringer Ingelheim International GmbH – Overview
Exhibits139: Boehringer Ingelheim International GmbH – Business segments
Exhibits140: Boehringer Ingelheim International GmbH – Key news
Exhibits141: Boehringer Ingelheim International GmbH – Key offerings
Exhibits142: Boehringer Ingelheim International GmbH – Segment focus
Exhibits143: CAMP4 – Overview
Exhibits144: CAMP4 – Product / Service
Exhibits145: CAMP4 – Key offerings
Exhibits146: Eurocept B.V. – Overview
Exhibits147: Eurocept B.V. – Product / Service
Exhibits148: Eurocept B.V. – Key offerings
Exhibits149: Horizon Therapeutics Plc – Overview
Exhibits150: Horizon Therapeutics Plc – Business segments
Exhibits151: Horizon Therapeutics Plc – Key news
Exhibits152: Horizon Therapeutics Plc – Key offerings
Exhibits153: Horizon Therapeutics Plc – Segment focus
Exhibits154: Medunik USA – Overview
Exhibits155: Medunik USA – Product / Service
Exhibits156: Medunik USA – Key offerings
Exhibits157: Orpharma Pty Ltd. – Overview
Exhibits158: Orpharma Pty Ltd. – Product / Service
Exhibits159: Orpharma Pty Ltd. – Key offerings
Exhibits160: Recordati S.p.A – Overview
Exhibits161: Recordati S.p.A – Business segments
Exhibits162: Recordati S.p.A – Key offerings
Exhibits163: Recordati S.p.A – Segment focus
Exhibits164: RELIEF THERAPEUTICS Holding SA – Overview
Exhibits165: RELIEF THERAPEUTICS Holding SA – Product / Service
Exhibits166: RELIEF THERAPEUTICS Holding SA – Key offerings
Exhibits167: Synlogic Inc. – Overview
Exhibits168: Synlogic Inc. – Product / Service
Exhibits169: Synlogic Inc. – Key offerings
Exhibits170: Ultragenyx Pharmaceutical Inc. – Overview
Exhibits171: Ultragenyx Pharmaceutical Inc. – Product / Service
Exhibits172: Ultragenyx Pharmaceutical Inc. – Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations